Rare Diseases of the Anterior Segment of the Eye: Update on Diagnosis and Management

Affiliations

¹ Department of Sense Organs, Sapienza University of Rome, Viale del Policlinico, No. 155, 00196 Rome, Italy.
² Department of Biology, College of Science and Technology, Temple University, 1900 N. 12th Street, Philadelphia, PA 19122, USA.
³ Cornea and Ocular Surface Unit, San Raffaele Hospital, Via Olgettina, No. 60, 20132 Milan, Italy.
⁴ Queen Alexandra Hospital, Southwick Hill Road, Cosham PO6 3LY, UK.
⁵ Scheie Eye Institute, University of Pennsylvania, 51 N. 39th Street, Philadelphia, PA 19104, USA.

Editorial

Alessandro Lambiase et al. Biomed Res Int. 2015.

. 2015:2015:947326.

doi: 10.1155/2015/947326. Epub 2015 Sep 27.

¹ Department of Sense Organs, Sapienza University of Rome, Viale del Policlinico, No. 155, 00196 Rome, Italy.
² Department of Biology, College of Science and Technology, Temple University, 1900 N. 12th Street, Philadelphia, PA 19122, USA.
³ Cornea and Ocular Surface Unit, San Raffaele Hospital, Via Olgettina, No. 60, 20132 Milan, Italy.
⁴ Queen Alexandra Hospital, Southwick Hill Road, Cosham PO6 3LY, UK.
⁵ Scheie Eye Institute, University of Pennsylvania, 51 N. 39th Street, Philadelphia, PA 19104, USA.

No abstract available

References

1. Angelis A., Tordrup D., Kanavos P. Socio-economic burden of rare diseases: a systematic review of cost of illness evidence. Health Policy. 2015;119(7):964–979. doi: 10.1016/j.healthpol.2014.12.016. - DOI - PubMed
1. Recupero S. M., Abdolrahimzadeh S., De Dominicis M., Mollo R. Sturge-Weber syndrome associated with naevus of Ota. Eye. 1998;12(2):212–213. doi: 10.1038/eye.1998.50. - DOI - PubMed
1. Ito Y. A., Walter M. A. Genomics and anterior segment dysgenesis: a review. Clinical & Experimental Ophthalmology. 2014;42(1):13–24. doi: 10.1111/ceo.12152. - DOI - PubMed
1. Ferrari M. P., Mantelli F., Sacchetti M., et al. Safety and pharmacokinetics of escalating doses of human recombinant nerve growth factor eye drops in a double-masked, randomized clinical trial. BioDrugs. 2014;28(3):275–283. doi: 10.1007/s40259-013-0079-5. - DOI - PMC - PubMed
1. Rama P., Matuska S., Paganoni G., Spinelli A., De Luca M., Pellegrini G. Limbal stem-cell therapy and long-term corneal regeneration. The New England Journal of Medicine. 2010;363(2):147–155. doi: 10.1056/nejmoa0905955. - DOI - PubMed